 Dr. Jon Aster studies cellular signaling pathways involved in cancers of the blood as potential targets for cancer therapies.
|  Dr. Peter Black is investigating the molecular mechanisms that underlie the unrelenting growth and recurrence of common brain tumors to support the development of new treatment strategies .
|
 Dr. Stephen Blacklow studies cell surface receptors involved in a wide variety of disorders, including heart disease and cancer, with a goal of providing new opportunities for the development of targeted therapies.
|  Dr. Raphael Bueno seeks to develop novel new tools for the diagnosis, prognosis, and treatment of thoracic cancers, including lung cancer and malignant pleural mesothelioma.
|
 Dr. Rona Carroll's work focuses on the development of novel therapies for controlling brain tumor growth using new and improved drug delivery systems.
|  Dr. Charles Dimitroff and his team illuminate how immune cells travel to inflamed skin and how prostate tumor cells form secondary tumors in other parts of the body.
|
 Dr. Omid Farokhzad develops targeted nanoparticles for the treatment of breast, prostate, ovarian, and pancreatic cancer.
|  Dr. Gavin Gordon's laboratory seeks to improve the clinical management of thoracic malignancies by improving early detection and diagnosis, development of clinical tests for prognosis and discovery and preclinical testing of novel therapeutics.
|
 Dr. Sue Hankinson uses biomarkers to study relationships between hormones and subsequent risk of breast, endometrial, and ovarian cancers.
|  Dr. Mark Johnson's research is focused on finding new and better ways to treat gliomas, a class of tumors that arise in the brain.
|
 Dr. Karl Kelsey's interests center on exposure-related diseases, using biomarkers and epidemiology to examine the effects of known and suspected carcinogens, including asbestos, on populations.
|  Dr. Elliott Kieff's viral oncology group focuses mainly on three oncogenic viruses: EBV; Kaposi’s sarcoma-associated herpesvirus, also known as human herpesvirus 8 (HHV8); and human papillomavirus (HPV), which has been implicated in cervical cancer.
|
 Dr. Thomas Kupper's research focuses on the immune system; how it recognizes invaders and how our largest body organ, the skin, protects the individual from the external environment.
|  Dr. David Kwiatkowski is an acknowledged expert on tuberous sclerosis (TS), a rare genetic disorder in which multiple tumors develop in many different organs, including brain, kidney, lung, and skin.
|
 Dr. Cynthia Casson Morton's research focuses on using genetic information to differentiate the projected clinical course of various tumors, including solid uterine fibroids.
|  Dr. Karl Münger's work is centered on understanding the role of human papillomavirus (HPV) in cervical cancer.
|
 Dr. David Sugarbaker's research emphasises lung cancer and mesothelioma; as founder and current director of the International Mesothelioma Program, he and his colleagues are at the forefront of translational research to find a definitive cure for these diseases.
|  Dr. Clare Tempany's research involves multidisciplinary applications of radiologic imaging, including image-guided therapy, MR-guided focused ultrasound surgery (MRgFUS) interventions, and MR-guided surgical procedures which can be used to treat patients with breast cancers, uterine fibroids, as well as tumors of the gastrointestinal tract, prostate, brain, bone, and liver.
|
 Dr. Fred Wang's research concerns the pathogenesis of Epstein-Barr Virus (EBV) infection: how it successfully infects humans, how it persists in humans, and how and why it is associated with certain kinds of cancer.
|  Dr. Walter Willett devotes his energies to research activities that center on the development of nutritional epidemiology.
|